Neocortix contributes to COVID-19 research by opening up the world of 64-bit Arm devices for Folding@Home and Rosetta@Home

Distributed computing company Neocortix announced that it has completed porting Folding@Home and Rosetta@Home to the 64-bit Arm platform, enabling modern smartphones, tablets and embedded systems like the Raspberry Pi 4 to contribute to the research and development of a COVID vaccine. -19.

four months ago Neocortix announced the launch of the Rosetta@Home port, allowing Arm devices to participate in a protein folding study aimed at finding a vaccine for COVID-19. At the time, the company said it was working on a port to Arm Folding@Home, another distributed computing project that aims to achieve the same goal.

Now Neocortix is ​​reporting success on both fronts. “We ported Folding@Home and Rosetta@Home to Arm-based devices to enable billions of high-end mobile devices to work on finding a vaccine for COVID-19,” explains Lloyd Watts, founder and CEO of Neocortix. “We saw an opportunity to use our Neocortix Cloud Services platform to help the most in-demand science projects with their computing needs, and we did it on a grand scale.”

"We're moving into a trillion-device-connected future, and the innovation is that this approach solves one of the biggest challenges of linking multiple devices around the world into a single cloud," adds Paul Williamson, Vice President and General Manager, Communications with Arm's business clients, "Arm's collaboration with Neocortix means that Arm technologies can now contribute to critical COVID-19 research and it's amazing to see the global ecosystem of Arm developers coming together to support this effort together."

“We have seen an increase in the processing power of phones and other mobile devices in recent years,” agrees Greg Bowman, director of the Folding@Home project. “This collaboration between Neocortix and Arm has provided us with an ideal opportunity to leverage mobile resources to accelerate our research on COVID-19 ".

Folding@Home and Rosetta@Home are already running on the Neocortix Scalable Compute distributed computing platform and are feeding results back into research projects. Additional technical details can be found in "Coronablog" Neocortix.

Source: habr.com